See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!

Join us! · InformexUSA 2012 · New Orleans, Louisiana · February 14-17, 2012 · Booth 2514

Research Area · Vascular Disease

· See all 100+ product categories

Item Number Product Sizes & Pricing CAS Purity Image Exclusive Introduction Date Mojo Plain Text Name Synonyms Keywords Interest
10462 11(12)-EpETE Exclusive 504435-15-8 ≥98% ✓ 2010-10-28 7.280628453038 11-12-epete 11,12-EEQ; 11,12-Epoxyeicosatetraenoic Acid eicosapentaenoic acids EPAs epoxyeicosatetraenoic EpETE EETeTr cytochromes P450 epoxygenases CYP450 10-[3-2Z,5Z-octadien-1-yl-2-oxiranyl]-5Z,8Z-decadienoic acid 11,12-epoxyeicosatrienoic acid 7.280628453038
519510 11-dehydro Thromboxane B2 EIA Kit - Monoclonal New - 2012-02-08 215.601734960098 11-dehydro-thromboxane-b2-eia-kit-monoclonal 11-dehydro TXB2 ELISA Kit 11-dehydro-TXB2 enzymes immunoassays EIAs ELISAs kits assays measures measurements competitive quantification thromboxanes A2 TXA2 arachidonic acids platelets aggregation vascular bronchial smooth muscles hydrolyzed plasma urine ex vivo activation intra-renal production metabolites kidneys metabolized dehydrogenases enzymes cytosolic aldehydes peroxisomes peroxisomal b-oxidations beta-oxidations .beta.-oxidations β-oxidations infusions study studies circulating half-life t1/2 2,3-dinor 11-dehydro-2,3-dinor gas chromatography mass spectrometry GC/MS dosing doses aspirin acetylsalicylic acid NSAIDS nonsteroidal anti-inflammatory drugs smokers levels non-enzymatically 215.601734960098
13571 13,14-dihydro-15-keto-tetranor Prostaglandin F1α Exclusive 24379-94-0 ≥98% ✓ 2009-11-05 0.044198895027 13-14-dihydro-15-keto-tetranor-prostaglandin-f1 metabolites PGF1α PGF2α tetranors PGFM prostaglandins PGs urinary metabolites prostanoic acids C13 C-13 C14 C-14 C15 C-15 0.044198895027
10004946 14,15-EE-5(Z)-E Exclusive 519038-92-7 ≥98% ✓ 2007-01-15 34.172044198895 14-15-ee-5-z-e 14,15-Epoxyeicosa-5(Z)-enoic Acid 14,15-EpETrE 14,15-EETs antagonists hypertension vasodilation vasodilator vasoconstriction vasoconstrictor EDHT endothelium-derived hyperpolarizing factor U46619 bovine arteries endocrinology EEZE 34.172044198895
10010486 14,15-EE-8(Z)-E Exclusive 519038-93-8 ≥98% ✓ 2008-11-03 13.297796193983 14-15-ee-8-z-e 14,15-Epoxyeicosa-8(Z)-enoic Acid 14,15-EETs 14,15-EpETrEs vasodilation vascular disease hypertension EEZE 13.297796193983
10008510 15(R)-Pinane Thromboxane A2 - >98% 2006-06-14 3.591104972376 15-r-pinane-thromboxane-a2 15(R)-PTA2 TXA2 anatagonists TP receptors synthases platelets aggregation analogs inhibits inhibitors inhibition U-46619 cat coronary artery constriction 15-epimer 3.591104972376
10010635 (±)16-HETE 128914-46-5 ≥98% 2008-06-09 24.688839779005 -16-hete CYP450 eicosanoid metabolism kidneys ATPase ion transport vasodilation renal hypertension 24.688839779005
10991 16(R)-AFP 07 (free acid) Exclusive 773525-80-2 ≥98% ✓ 2011-08-16 52.354989752770 16-r-afp-07-free-acid prostaglandins I2 PGI2 prostacyclin IP receptors agonists EP1 EP2 EP3 EP4 AH 23848 PGs prostacyclin AFP-07 AFP07 EP prostanoids 52.354989752770
10010638 (±)18-HETE 133268-58-3 ≥97% 2008-06-13 6.341436464088 -18-hete CYP450 eicosanoid metabolism kidney vasodilation CYP2E1 20-HETE 20HETE 18HETE renal hypertension 6.341436464088
10007767 19(R)-HETE 115461-39-7 ≥98% 2008-05-27 7.770165745856 19-r-hete hypertension arterioles CYP450 kidneys angiotensin II vasodilator vasoconstricition 20-HETE 19HETE 19-HETE renal 19 HETE 7.770165745856
10007766 19(S)-HETE Exclusive 115461-40-0 ≥98% ✓ 2010-04-06 27.706500920810 19-s-hete cytochromes P450 CYP450 metabolites arachidonic acids kidneys angiotensin II CYP2E1 vasodilators renal preglomerular vessels ATPase hypertension arterioles vasoconstriction Acids Hydroxyeicosatetraenoic Hydroxyeicosatetraenoic Acids HETE 27.706500920810
13050 1a,1b-dihomo Prostaglandin E1 - >98% 19.342651933702 1a-1b-dihomo-prostaglandin-e1 1a,1b-dihomo PGE1 1a,1b-dihomo-PGE1 prostaglandins 19.342651933702
9000462 2,3-dinor-6-keto Prostaglandin F1α-d9 (sodium salt) - ≥99% deuterated product 2010-05-07 20.833834254144 2-3-dinor-6-keto-prostaglandin-f1-d9-sodium-salt 2,3-dinor-6-keto PGF1α-d9 (sodium salt) PGI2 metabolites 2,3-dinor-6-keto-PGF1alpha 2,3-dinor-6-keto-PGF1.alpha. prostaglandins PGs MS LC-MS LC/MS GC-MS GC/MS mass spectrometry deuterium deuterated 20.833834254144
515121 2,3-dinor-6-keto Prostaglandin F1α EIA Kit - 2006-05-23 157.716198895028 2-3-dinor-6-keto-prostaglandin-f1-eia-kit 2,3-dinor-6-keto PGF1α ELISA Kit solid plates enzymes immunoassays Prostaglandins PGI2 prostacyclin vascular myocardial infarction inhibits cyclooxygenases atherosclerosis stroke COX-2 measures kits PGF1a assays 157.716198895028
15120 2,3-dinor-6-keto Prostaglandin F1α (sodium salt) - ≥95% 15.906215469613 2-3-dinor-6-keto-prostaglandin-f1-sodium-salt 2,3-dinor-6-keto PGF1α (sodium salt) PGI2 metabolites 2,3-dinor-6-keto-PGF1alpha 2,3-dinor-6-keto-PGF1.alpha. prostaglandins 15.906215469613
13120 2,3-dinor Prostaglandin E1 7046-40-4 >98% 31.806685082873 2-3-dinor-prostaglandin-e1 2,3-dinor PGE1 prostaglandins 2,3-dinor-PGE1 erectile dysfunction 31.806685082873
10006330 2,3-dinor Thromboxane B1 - >98% 2005-03-02 88.317103393843 2-3-dinor-thromboxane-b1 2,3-dinor TXB1 metabolites thromboxanes urine urinary 2,3-dinor-TXB2 11-dehydro TXB2 biosynthesis humans rats markers rabbits 88.317103393843
10467 5,6-DiHETE Exclusive 845673-97-4 ≥97% ✓ 2011-06-13 5.373638516179 5-6-dihete eicosapentaenoic acids EPAs cytochromes P450 P-450 metabolites polyunsaturated fatty metabolites ω-3 omega epoxidation 5(6)-DiHETE DiHETEs epoxide hydrolases CYP450 5.373638516179
10009315 6-Aminonicotinamide 329-89-5 ≥98% 2008-11-21 2.086464088398 6-aminonicotinamide 6-AN; NSC 21206; SR 4388 inhibitors inhibits inhibition 6-phosphoguconate dehydrogenase cancers ATPs oxidative injury neurodegeneration cardiovascular 2.086464088398
15210 6-keto Prostaglandin F1α 58962-34-8 >99% 56.309966850828 6-keto-prostaglandin-f1 6-keto PGF1α PGI2 metabolites prostaglandins 6-keto-PGF1alpha 6-keto-PGF1.alpha. atherosclerosis 56.309966850828
515211 6-keto Prostaglandin F1α EIA Kit - 520.380412318396 6-keto-prostaglandin-f1-eia-kit 6-keto Prostaglandin F1α ELISA Kit solid plates 6-keto-PGF1alpha 6-keto-PGF1.alpha. prostaglandins measures kits eias atherosclerosis enzyme immunoassays ELISAs 6-keto Prostaglandin F1.alpha. EIA Kit assays 520.380412318396
10007219 6-keto Prostaglandin F1α Lipid Maps MS Standard 58962-34-8 >99% 2008-12-17 37.604464088398 6-keto-prostaglandin-f1-lipid-maps-ms-standard 6-keto PGF1α PGI2 metabolites prostaglandins 6-keto-PGF1alpha 6-keto-PGF1.alpha. atherosclerosis PGs MS mass spectrometry standards 37.604464088398
18112 8,9-EE-14(Z)-E Exclusive - ≥95% ✓ 2009-03-15 9.932679558011 8-9-ee-14-z-e 8,9-Epoxyeicosa-14(Z)-enoic Acid 14,15-EETs 14,15-EpETrEs vasodilation vascular disease hypertension EEZE 9.932679558011
10007850 9,11-methane-epoxy Prostaglandin F1α 72517-81-8 >96% 2006-05-10 182.245248618784 9-11-methane-epoxy-prostaglandin-f1 9,11-Epoxymethano PGH1 prostaglandins PGs endoperoxides TXs thromboxanes prostacyclins PGH1 platelets smooth muscles analogs aggregation aorta aortic tracheas histamines coronary perfusion atherosclerosis 182.245248618784
10010569 Acenocoumarol 152-72-7 ≥98% 2008-07-25 5.517856353591 acenocoumarol Sintrom®; Acenocoumarin; Nicoumalone; G-23350; Sinthrome® CYP450 thrombosis vitamin K warfarin bleeding blood coagulation inhibitors inhibits inhibition 5.517856353591
10092 Adenosine Receptor A2A Blocking Peptide - 2009-04-03 152.562306629834 adenosine-receptor-a2a-blocking-peptide A2AR blocking peptides Western blots immunoblotting ARA2A 152.562306629834
13626 AFP 07 (free acid) Exclusive New 788799-13-3 ≥98% ✓ 2011-08-31 9.319906478595 afp-07-free-acid prostaglandins I2 PGI2 PGs prostacyclins IP receptors agonists EP1 EP2 EP3 EP4 AH 23848 AH-23848 prostanoids platelets vasodialation aggregation pulmonary vascular AH23848 AFP07 AFP-07 9.319906478595
13523 Apelin-13 217082-58-1 ≥95% 2010-06-29 51.080481452249 apelin-13 ligands APJ receptors central nervous system cardiovascular functions fluid homeostasis neurosciences hypertension diabetes metabolic syndrome insulin HIV aids Peptide Factors Paracrine Paracrine Protein Factors Paracrine Peptide Factors Growth Factors 51.080481452249
13524 Apelin-36 252642-12-9 ≥95% 2011-04-04 55.485883977900 apelin-36 agonists receptors APJ cardiovascular functions fluids homeostasis hypertension insulin sensitivity apelin-17 apelins 17 13 36 apelin-13 HIV infections peptides mature G protein-coupled GPCR c-protein coupled 55.485883977900
13079 ApoAI Blocking Peptide - 2008-09-30 18.108287292818 apoai-blocking-peptide Apolipoprotein A-I; Apolipoprotein AI antibodies antibody peptides antiserum antisera blocking immunoblotting WB western blots 18.108287292818
13042 ApoAI Monoclonal Antibody (Clone CC3821C4) Exclusive - ✓ 2008-10-15 23.606390423572 apoai-monoclonal-antibody-clone-cc3821c4 Apolipoprotein AI antibodies HDL high-density lipoproteins WB western blots polypeptide immunoblotting blotting A-I A-1 apopipoproteins 23.606390423572
13644 Aspalatone Exclusive 147249-33-0 ≥98% ✓ 2010-02-19 3.789786898184 aspalatone Acetylsalicylic Acid Matol ester antioxidants platelet aggregation thrombosis epilepsy kainic acid thromboembolism anti-platelets antiplateles 2-(Acetyloxy)benzoic Acid Acid, Acetylsalicylic Acetylsalicylic Acid Aloxiprimum Polopiryna Polopirin Micristin Endosprin Acylpyrin Solupsan Magnecyl Colfarit Acetysal Zorprin Solprin Ecotrin Easprin Dispril Aspirin 3.789786898184
10010153 Aspirin™ Effect-Detection Kit - 2007-06-08 112.700382647841 aspirin-effect-detection-kit use:human 11-dehydro-TXB2 enzyme immunoassays ELISAs kits measures metabolites atherosclerosis thromboxanes eias analysistools:eia atherosclerosis cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits atherosclerosis assays 112.700382647841
10011131 BAY-41-8543 Exclusive 256498-66-5 ≥98% ✓ 2009-11-16 21.308107887258 bay-41-8543 soluble guanylate cyclase sGC nitric oxide NO GTP cyclic GMP cGMP agonist stimulator platelet aggregation blood pressure bleeding time thrombosis pulmonary hypertension BAY 41-8543 BAY 41 8543 21.308107887258
10011135 BAY-60-7550 439083-90-6 ≥95% 2009-03-13 62.156844151329 bay-60-7550 inhibitors inhibits inhibition cyclic nucleotides cGMP cAMP cells signalling signaling PDE2 memory memories phosphodiesterase 62.156844151329
10005186 CAY10441 Exclusive 221529-58-4 >98% ✓ 2004-09-16 119.233397790055 cay10441 RO1138452 receptors antagonists IPs prostaglandins carbaprostacyclins inhibits inhibitors inhibition analgesics high-affinity ligands neuroblastoma cyclic AMP cAMP adenylate cyclase 4,5-dihydro-1H-imidazol-2-yl-4-4-isopropoxy benzyl phenylamine atherosclerosis 119.233397790055
10005913 CAY10449 Exclusive - >98% ✓ 2004-10-26 93.114659300184 cay10449 receptors antagonists IPs prostaglandins carbaprostacyclins inhibits inhibitors inhibition analgesics high-affinity ligands neuroblastoma adenylate cyclase cyclic AMP cAMP iloprost athersclerosis CAY 10449 93.114659300184
10010396 CAY10535 Exclusive - >98% ✓ 2008-05-06 191.776795580111 cay10535 TPbeta TPb TP.beta. TPalpha TP.alpha. TPa TXA2 thromboxanes antagonists platelet aggregations U-46619 U46619 191.776795580111
10012447 CG 4305 - ≥95% 2010-05-12 50.951981057616 cg-4305 antithrombotic PGI2 epoprostenol prostacyclins platelets aggregation 89955-40-8 PGs prostaglandins I2 cartoid artery thrombosis inhibits inhibited inhibition inhibitory Epoprostenol Sodium(5Z,9alpha,11alpha,13E,15S)Isomer Epoprostenol Sodium Prostaglandin I(2) Prostaglandin I2 Prostacyclin Epoprostenol Epoprostanol Flolan PGI2 PGX 50.951981057616
10325 Chemokine-Like Receptor 1 Polyclonal Antibody - 2010-01-25 65.399367710251 chemokine-like-receptor-1-polyclonal-antibody Resolvin E1 Receptor; GPCR ChemR23; ChemerinR; DEZ; CMKLR1; ChemR23 immunohistochemistry antibodies western blots WB IHC ChemerinR immunoblotting blotting DEZ ChemerinR 65.399367710251
700610 Chloride Colorimetric Assay Kit New - 2011-11-18 99.084969590039 chloride-colorimetric-assay-kit chlorides Cl assays kits measures measurements plasma serums urine saliva cells cultures lysates Hg2+ Fe2+ mercury iron mercury-thiocyanate Hg-thiocyanate thiocyanates mercuric mineral humans anions hydration osmotic pressure cation-anion balance vascular intestinal fluids compartments hypochloremia hyperchloremia vomiting renal diseases metabolic acidosis burns dehydration diarrhea congestive heart failure hyperventilation kidneys Lightwood syndromes parathyroid glands pathological ions channels Cystic Fibrosis myotonia congenita Barter's Syndrome 2002 bestrophins proteins hbest1 retinal progressive vision loss vitelliform macular dystrophy Best 99.084969590039
10009779 Cholesterol Cell-Based Detection Assay Kit - 2007-05-04 57.098345374698 cholesterol-cell-based-detection-assay-kit Fluorescence Kits Metabolism coronary heart diseases LDL lipoproteins ADHP atherosclerosis fluorescent fluorometric assays cell-based assay cell based assays cba U18666A U 18666A U-18666A 57.098345374698
16831 Cicaprost Exclusive 94079-80-8 ≥98% ✓ 2010-09-16 53.389462581616 cicaprost ZK 96480 Prostaglandin I2 PGI2 prostacyclins vasodilators cardiovascular diseases inflammation mitogenesis cancers orally active inflammatory Epoprostenol Sodium(5Z,9alpha,11alpha,13E,15S)-Isomer Epoprostenol Sodium Prostaglandin I(2) Prostaglandin I2 Prostacyclin Epoprostenol Epoprostanol Flolan PGI2 PGX 53.389462581616
13657 (±)-Clopidogrel (hydrochloride) 90055-48-4 ≥98% 2011-04-11 0E-12 -clopidogrel-hydrochloride platelets aggregation antagonists P2Y12 receptors ADPs prodrugs anti-thrombic antithrombic 0E-12
10010948 DL-Propargyl Glycine (hydrochloride) - ≥98% 2008-08-19 43.013158379374 dl-propargyl-glycine-hydrochloride PAG (hydrochloride) H2S gasotransmitter inhibitor inhibits inhibition CSE vasodilation inflammation propargylglycine 43.013158379374
9000295 Eicosapentaenoic Acid methyl ester New 2734-47-6 ≥98% 2011-10-07 41.874288583402 eicosapentaenoic-acid-methyl-ester EPA vascular cardiovascular diseases immunity resolvins autoimmunity nephritis glomerulonephritis inflammation anti-inflammatory resolutions prodrugs antiinflammatory anti inflammatory immune physiology resolvins pro-drugs hydrolyzed esterases cells EPAs 41.874288583402
10010380 ent-8-iso-15(S)-Prostaglandin F2α - ≥98% 2008-04-24 10.323038674033 ent-8-iso-15-s-prostaglandin-f2 ent-8-iso-15-epi-PGF2α; ent-15-epi-F2t-Isoprostane inhibitors inhibits inhibition 8-iso-PGF2.alpha. vasoconstriction platelet aggregation oxidative stress isoprostanes 15-F2t-isoprostane prostaglandins 10.323038674033
10233 FABP3 Monoclonal Antibody (Clone CC68) - 2009-03-20 8.984487415591 fabp3-monoclonal-antibody-clone-cc68 Cardiac FABP; Fatty acid binding protein 3; Heart fatty acid binding protein; H-FABP antibody antisera antiserum antibodies wb western blots immunoblotting small endogenous exogenous lipophilic ligands uptake metabolism cellular membranes levels intracellular trafficking substrates modulation enzymes lipid metabolic pathways cells growth differentiation antiparallel .beta. strands barrel cytosolic tissues biomarker myocardial injury infarction atherosclerosis endocrinology blotting 8.984487415591
10005368 Fenofibrate 49562-28-9 ≥98% 2004-09-15 22.251700429711 fenofibrate PPAR.alpha. PPARalpha ligands selective peroxisome proliferator-activated receptors nuclear fibrate agonists lipids dyslipidemia fatty acids b-oxidation beta-oxidation .beta.-oxidation hypolipidemic drugs cardiovascular diseases atherosclerosis endocrinology 22.251700429711
10006407 FTY720 (R)-Phosphate Exclusive 402616-23-3 ≥98% ✓ 2009-05-27 87.025823204419 fty720-r-phosphate FTY720 sphingosines sphingosine-1-phosphates S1P S1P1 S1P3 S1P4 S1P5 immunosupression immune modulators transporters cPLA2 cytosolic phospholipase A2 endothelial cells barrier functions immunosuppression FTY-720 FTY 720 87.025823204419
10006408 FTY720 (S)-Phosphate 402616-26-6 ≥98% 2009-05-27 112.287701657458 fty720-s-phosphate (S)-FTY 720P FTY720 sphingosines sphingosine-1-phosphate S1P S1P1 S1P3 S1P4 S1P5 immunosuppression immune modulators Abcc1 Abcb1 transporters cPLA2 cytosolic phospholipase A2 endothelial cells barriers functions FTY720P 112.287701657458
13311 Gö 6983 133053-19-7 ≥98% 2009-10-07 38.994546756701 g-6983 proteins kinases C PKC α β γ δ ζ µ hearts cardioprotection ischemia reperfusion injuries contractile dyfunction alpha beta gamma delta zeta micro Goe Goe6983 Go-6983 Go 6983 38.994546756701
10136 GPR17 (C-Term) Polyclonal Antibody - 2010-01-19 13.055138121547 gpr17-c-term-polyclonal-antibody G Protein-Coupled Receptor 17 proteins receptors antibodies western blots WB ICC signals signaling nucleotides CysLTs amino acids blotting immunoblotting FC flow cytometry immunocytochemistry cysteinyl leukotrienes 13.055138121547
13009 GSK264220A 685506-42-7 ≥98% 2009-10-21 5.716298342542 gsk264220a inhibitors endothelial lipases high-density lipoproteins cholesterol HDL-C HDL cardiovascular diseases inhibition inhibited ET 5.716298342542
10851 Guanabenz (hydrochloride) New - ≥98% 2011-09-30 0.603038674033 guanabenz-hydrochloride Wytensin adrenergic receptors hypertension imidazoline adipose tissues neurosciences cardiovascular diseases agonists 5051-62-7 α2 alpha2 I2 hydrochloride HCl 0.603038674033
13345 GYY 4137 Exclusive 106740-09-4 ≥95% ✓ 2009-07-31 111.395851749539 gyy-4137 hydrogen sulfides H2S gaseous mediators nitric oxides NOs donors vasodilator antihypertensive anti-hypertensive rats spontaneously hypertensive hypertension models endotoxic shock TNF-α TNFα TNF α TNF-a TNFa IL-1b IL1b IL-1β IL1β IL-6 IL6 NFkB NF-kB NF-κB NFκB iNOS COX-2 COX2 PGE2 110-91-8 106740-08-3 111.395851749539
10010559 HA-1077 (hydrochloride) 203911-27-7 ≥98% 2008-09-03 68.667826887661 ha-1077-hydrochloride Eril; Fasudil; AT-877 protein kinase inhibitors inhibits inhibition ROCK-II ROCKII PRK2 MSK1 MAPKAP-K1b vasodilation hypertension diabetes renal nephropathy cancers 105628-07-7 AT877 AT 877 hydrochloride dihydrochloride monohydrochloride HCl HA1077 HA 1077 68.667826887661
700540 Hemoglobin Colorimetric Assay Kit - 2011-05-23 128.901586249233 hemoglobin-colorimetric-assay-kit kits assays measures measurements Hb Hgb globular proteins oxygen O2 lungs tissues cells carbon dioxide CO2 erythrocytes human molecules subunits chains heme groups charged iron Fe Fe2+ tetrapyrrole rings porphyrin covalent bonds monoxide nitric oxides NO hypoxia thiol S-nitrosothiol vasodilatory effects transport hypoxic red blood RBCs vessels sickle-cell anemia thalassemia bone marrow diseases kidney diabetes 128.901586249233
10347 HIF-1α Monoclonal Antibody (Clone H1α67) - 2011-05-09 50.193591160220 hif-1-monoclonal-antibody-clone-h1-67 Hypoxia Inducible Factor-1α WBs western blots IHC immunohistochemistry antibodies HIF-1alpha HIF1a HIF-1a antisera serum cancers H1α67 transcription factors oxidative tumors EPAS-1 EPAS1 EPAS 1 DMOG 2,4-DPD desferrioxamine CoCl2 50.193591160220
11514 HMGB1 Monoclonal Antibody (Clone IMG19N12A1) - 77.222222222222 hmgb1-monoclonal-antibody-clone-img19n12a1 High Mobility Group Protein B1; HMG1 high mobility groups proteins B1 HMGB family DNA-binding domains nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear bindings sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting 77.222222222222
11515 HMGB1 Polyclonal Antibody (aa 100-150) New - 2012-01-20 134.722222222222 hmgb1-polyclonal-antibody-aa-100-150 HMG1; High Mobility Group Protein B1 high mobility groups proteins B1 HMGB family DNA-binding domains nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear bindings sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting flows cytometry FC immunohistochemistry IHC 134.722222222222
11516 HMGB1 Polyclonal Antibody (aa 25-75) New - 2012-01-30 143.055555555555 hmgb1-polyclonal-antibody-aa-25-75 HMG1; High Mobility Group Protein B1 high mobility groups proteins B1 HMGB family DNA-binding domains nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear bindings sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting 143.055555555555
13624 Icariin 489-32-7 ≥97% 2010-02-11 1.738950276242 icariin PDE5 inhibitors flavonoids differentiation cancers proliferation flavonols E brevicornum horny goat weed BMP2 ED erectile dysfunction 2-Phenyl-Benzopyrans 2 Phenyl Benzopyrans 2-Phenyl-Chromenes 2 Phenyl Chromenes Bioflavonoids Flavonoids 1.738950276242
10009458 JTE-013 383150-41-2 ≥98% 2007-01-18 97.558465316145 jte-013 reverses inhibition inhibits coronary artery smooth muscles lipids cells proliferation cytoskeletal morphogenesis GPCRs protein-coupled receptors antagonists S1P2 humans rats EDG5 sphingosines sphingosine-1-phosphates sphingosine1 inhibitors JTE013 FDG-5 cancers 97.558465316145
10011562 L-655,240 103253-15-2 ≥98% 2009-10-15 6.484599447513 l-655-240 platelet aggregation smooth muscle constriction contraction antagonist receptors TXA2 receptor TP thromboxane TPα TPβ TXA2 bronchoconstriction L-655240 L 655240 6.484599447513
10011125 LDL Uptake Cell-Based Assay Kit - 2008-04-29 36.676138668359 ldl-uptake-cell-based-assay-kit Low-Density Lipoprotein Uptake atherosclerosis cholestrols plasmas blood coronary heart diseases low-density lipoproteins kits assays assaying tools uptakes regulation 36.676138668359
16833 Lisinopril 76547-98-3 ≥98% 2009-03-09 2.545248618785 lisinopril MK 522; MK 521 inhibitors inhibits inhibition angiotensin I II ACE endothelin 1 nitric oxide renin hypertension diabetes 2.545248618785
10010971 Luminex® 11-dehydro Thromboxane B2 Kit - 2008-01-24 89.828657151627 luminex-11-dehydro-thromboxane-b2-kit Luminex® 11-dehydro TXB2 Kit thromboxanes thromboxane A2 TXA2 metabolites urine in vivo measures kits luminex xMAP beads assays 89.828657151627
600160 Methionine Sulfoxide Immunoblotting Kit - 2009-12-17 208.421613259668 methionine-sulfoxide-immunoblotting-kit MetO Immunoblotting Kit proteins sulfoxides oxidative modifications residues MSRs reactive oxygen species ROSs methionines oxidations reductases sulfones phagocytosis phagocytotic mitochondrias mitochondrial respirations sulfoxidations age-related diseases cellular cells IgG-containing sera Alzheimer's diseases immunoblots immunoblotting western blots blotting kits assays measures measurements detection tissues lysates semi-pure purified reducing non-reducing sample buffers SDS-PAGE rabbit serums immunizations oxidized corn MetO-DZS18 208.421613259668
10010252 Methyl-L-NIO (hydrochloride) 150403-96-6 >98% 2008-02-12 7.353508287293 methyl-l-nio-hydrochloride NOS L-arginine NO nitric oxide nNOS eNOS iNOS inhibitor inhibits inhibition vasodilation inflammation 7.353508287293
13357 Milrinone 78415-72-2 ≥98% 2011-03-07 274.534618088485 milrinone Primacor®; WIN 47203 inhibitors phosphodiesterases PDE3A PDE3B cAMP vascular diseases cardiovascular effects Sanofi Synthelabo Brand of Milrinone Lactate Sanofi Winthrop Brand of Milrinone Lactate Sanofi Synthelabo Brand of Milrinone Sanofi Brand of Milrinone Lactate Lactate Milrinone Milrinone Lactate Win-47203 Win 47203 Milrinone Corotrope Win47203 Primacor Corotrop inhibits inhibition 274.534618088485
10010412 MRE-269 Exclusive 475085-57-5 ≥98% ✓ 2008-11-06 64.629803080342 mre-269 MRE269 prostaglandins PGI2 IP receptors inflammation NS-304 NS304 agonists vasodilator hypotensive vascular diseases atherosclerosis hypertension analogs potent selective PGs prodrugs 64.629803080342
10004971 N,N'-Dicyclohexylurea 2387-23-7 ≥98% 2010-03-17 16.488798342541 n-n-dicyclohexylurea DCU; NSC 17013 hypertension Epoxyeicosatrienoic acids EETs soluble epoxide hydrolase sEH inhibitors inhibits inhibiting PPARα 1,3-dicyclohexylurea dicyclohexylcarbodiamide Doms-Adrian Brand of Alanine Doms Adrian Brand of Alanine Alanine Doms-Adrian Brand Alanine, L-Isomer Alanine, L Isomer L-Isomer Alanine L-Alanine L Alanine Alanine Abufène 16.488798342541
10010411 NS-304 475086-01-2 >98% 2008-04-09 41.397650158956 ns-304 ACT-293987; Selexipag prostaglandins PGI2 IP receptors inflammation MRE-269 agonists vasodilator hypotensive vascular diseases atherosclerosis hypertension analogs potent selective PGs 41.397650158956
10006803 O-1602 317321-41-8 >98% 2005-09-12 10.751519337016 o-1602 abnormal cannabidiols CB1 CB2 receptors vasorelaxation neurochemistry neuroscience central cannabinoids peripheral selective antagonists nonendothelium-dependant vasodilation nitric oxides NOs inhibits inhibitors inhibition vasorelaxant cannabinoids cbs synthetic 10.751519337016
10006804 O-1821 35482-50-9 >97% 2005-09-12 18.792081031307 o-1821 abnormal cannabidiol central cannabinoids peripheral CB1 CB2 receptors vasorelaxation neurochemistry neuroscience antagonists synthetic regioisomer endothelium dependent vasodilation cannabinoids cbs synthetic 18.792081031307
10004914 O-1918 536697-79-7 >98% 2005-09-09 9.388121546961 o-1918 antagonists abnormal cannabinoids cannabidiols cannabidiol-mediated synthetic regioisomers CB1 CB2 responsiveness psychotropics activity induces endothelium-dependent vasodilations NO-independent nitric oxides mechanisms analogs endothelial receptors inhibits inhibition inhibitors vasorelexants in vitro blocks induced activations PI3-kinases Akt pathway umbilical vein cells neuroscience neurochemistry O1918 0-1918 cannabinoids cbs synthetic 9.388121546961
13804 OU749 519170-13-9 ≥95% 2010-07-20 1.839779005525 ou749 γ-Glutamyl transferases γ-glutamyl transpeptidases glutathione markers liver dysfunction alcohol abuses biomarkers diabetes cardiovascular diseases cancers acivicin OU-749 OU 749 Mixtures Sulfonamide Sulfonamide Mixtures Sulfonamides 1.839779005525
10218 PCSK9 Monoclonal Antibody (Clone 15A6) - 2008-10-29 13.274198895027 pcsk9-monoclonal-antibody-clone-15a6 Proprotein Convertase Subtilisin Kexin 9; NARC-1 antibodies proproteins serine protease lipoproteins LDLs low density neural apoptosis-regulated convertase 1 blotting ligands western immunoblotting WB blots 13.274198895027
10010254 Pentosidine 124505-87-9 ≥98% 2011-02-10 19.966132596685 pentosidine advanced glycation end products AGEs RAGE glycosylation diabetes uremia aging rheumatic arthritis biomarkers 19.966132596685
11006 Piperlongumine New 20069-09-4 ≥98% 2011-10-24 59.638557257660 piperlongumine Piplartine 2859-009- 11042-67-4 25343-05-9 Keap1 Nrf2 antioxidants ROS cancers redox platelet aggregation tumorigenesis 59.638557257660
100023 Prostaglandin I Synthase (murine) Polyclonal Antibody - 2004-06-30 10.323301104972 prostaglandin-i-synthase-murine-polyclonal-antibody PGIS; Prostacyclin Synthase; PGI Synthase antibodies antisera antiserum western blots blotting wb IHC immunohistochemistry prostaglandins prostacyclins synthases receptors atherosclerosis immunoblotting 10.323301104972
9000336 (R)-(+)-Acenocoumarol 66556-77-2 ≥98% 2009-06-25 4.986364640884 -r-acenocoumarol (R)-(+)-Nicoumalone; (R)-(+)-Acenocoumarin thrombosis vitamin k warfarin bleeding blood coagulation inhibitors anticoagulants G-23350 Sintrom Sinthrome coumarins 4.986364640884
10012554 Resolvin D1 Exclusive 872993-05-0 ≥95% ✓ 2008-06-06 256.881973164956 resolvin-d1 RvD1; 17(S)-Resolvin D1 EPA DHA inflammation antiinflammatory anti-inflammatory immune responses aspirin LOX peritonitis LOS neurochemistry resolvins 256.881973164956
10006415 Ro 48-8071 161582-11-2 >98% 2005-06-01 6.522028413575 ro-48-8071 monooxidosqualenes cyclases inhibitors OSC cholesterols lowering activity microsomal enzymes catalyzes lanosterol synthetic pathway LDL low-density lipoproteins human livers microsomes HepG2 cells HDL high-desity toxicity CYP3A mRNA proteins hepatocytes cultures atherosclerosis 6.522028413575
9000337 (S)-(−)-Acenocoumarol 66556-78-3 ≥98% 2009-06-25 4.986364640884 -s-acenocoumarol (S)-(-)-Nicoumalone; (S)-(-)-Acenocoumarin thrombosis vitamin k warfarin bleeding blood coagulation inhibitors inhibition inhibits sintrom sinthrome G-23350 G23350 4.986364640884
89460 Sclerotiorin 549-23-5 ≥98% 2009-03-11 32.979650092081 sclerotiorin Lipoxygenase-1 inhibitor CETP Grb2 Endothelins ETa ETb LO-1 ETs LOs Penicillium soybean inhibits inhibition antagonism antagonists 32.979650092081
10005260 Serine Palmitoyltransferase Polyclonal Antibody - 2004-12-02 27.718979742173 serine-palmitoyltransferase-polyclonal-antibody Serine-palmitoyl-CoA transferase, long chain base subunit 2; SPT antibodies antisera western blots blotting WB sphingolipids SPT2 immunohistochemistry immunohistochemical analysis IHC nuclear proteins nucleus immunoblotting 27.718979742173
13332 (S)-Glycyl-H-1152 (hydrochloride) Exclusive 913844-45-8 ≥98% ✓ 2010-01-27 51.846950276243 -s-glycyl-h-1152-hydrochloride Rho Kinase Inhibitor IV Rho kinases ROCK-I p160ROCK ROCK-II G protein Rho cytoskeletons adhesions proliferation smooth muscles contraction stem cells inhibitors inhibition inhibited Fasudil hydrochloride ROCK IV h1152 h-1152 h 1152 51.846950276243
10007653 (S)-H-1152 (hydrochloride) 451462-58-1 ≥95% 2010-02-25 10.435580110497 -s-h-1152-hydrochloride Rho kinase ROCK cytoskeletal cytoskeleton smooth muscles contractions vasoconstriction neurons neurite inhibitors Y-27632 HA-1077 PKA PKC MLCK H1152 H 1152 inhibition inhibits 451462-58-1 1-(5-Isoquinolinylsulfonyl)-2-Methylpiperazine 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine H-7 H 7 h1152 h-1152 h 1152 10.435580110497
10011348 Taprostene (free acid) Exclusive 108945-35-3 ≥95% ✓ 2009-11-11 59.629788213627 taprostene-free-acid CG 4203; Rheocyclan prostacyclins PGI2 receptors IP IP1 EP4 vascular smooth muscles relaxation analogs potential antagonists tissues preparations CG-4203 CG4203 SE63 SE-63 SE 63 59.629788213627
10007565 Tetradecyl Phosphonate 4671-75-4 >98% 2005-10-17 43.010149960536 tetradecyl-phosphonate pan-antagonists LPA receptors lysophosphatic acids lipids signalling molecules hydrolysis lysophospholipase D autotoxin signals GPCRs G-protein coupled LPA1/EDG-2 LPA2/EDG-4 LPA3/EDG-7 LPA4/GPR23 activates activation PPAR.gamma. peroxisomes proliferator-activated inhibits inhibition LPA-induced calcium mobilization activates reporter 43.010149960536
10007349 TGX-221 663619-89-4 >98% 2006-02-21 22.249410681399 tgx-221 phosphatidylinositol-3-kinases PI3K catalyzes phosphorylation produces second messengers (3,4)-biphosphates -P2 (3,4,5)-P3 Class 1 p110.alpha. .beta. .delta. .gamma. p85 regulatory subunits cells permeable inhibitors inhibition inhibits ATP binding sites platelets defective thrombus formation antithrombotic therapy atherosclerosis 22.249410681399
11120 TPPU Exclusive New 1222780-33-7 ≥98% ✓ 2011-10-26 6.444971864129 tppu soluble epoxide hydrolase sEH inflammation hypertension cardiovascular disease neuroscience inhibitors inhibits inhibition pharmacokinetics 6.444971864129
10012559 TP Receptor (human) Polyclonal FITC Antibody - 2008-07-25 76.754683855126 tp-receptor-human-polyclonal-fitc-antibody TXA2 Receptor; Thromboxane A2 Receptor antibodies antiserum antisera thromboxane A2 TXA2 receptors flow cytometry FC IF immunofluorescence western blots blotting WB immunoblotting 76.754683855126
13044 Tranilast 53902-12-8 ≥98% 2008-08-29 83.935779005525 tranilast SB 252218; Rizaben; MK 341; Tranpro; N-(3',4'-Dimethyoxycinnamoyl)Anthranilic Acid anti-inflammatory antiinflammatory angiogenesis PGDF TGF-.beta.1 TGF.beta.1 IL-8 IL8 PGE2 TXB2 antiallergenic anti-allergenic atherosclerosis vascular disease VEGF 83.935779005525
10010522 U-46619 Glycine methyl ester - >98% 2008-03-24 104.347835258664 u-46619-glycine-methyl-ester TP receptors agonists inflammations PGH2 endoperoxides thromboxanes vasoconstriction analogs U46619 3 prodrugs forms 104.347835258664
10010992 W123 Exclusive - ≥98% ✓ 2008-11-14 52.076132596685 w123 FTY720 sphingosines sphingosine-1-phosphate receptors S1P S1P1 EDG1 EDG-1 inhibitors inhibits inhibition SEW2871 FTY 720 antagonist 52.076132596685
13531 (−)-Warfarin 5543-57-7 ≥98% 2009-10-01 19.882348066298 -warfarin (S)-Warfarin anticoagulants hearts attacks strokes clotting blood cardiovascular diseases vitamins K rodenticides warfarins anti-cogulants 19.882348066298
13526 (+)-Warfarin 5543-58-8 ≥98% 2009-10-01 10.528464088397 -warfarin (R)-Warfarin anticoagulants hearts attacks strokes clotting blood cardiovascular diseases vitamins K rodenticides warfarins anti-cogulants 10.528464088397
13566 (±)-Warfarin 81-81-2 ≥98% 2009-09-29 6.460441988950 -warfarin Coumadin; Zoocoumarin; Coumafene; Athrombine K; WARF 42 anticoagulants heart attacks strokes clotting blood cardiovascular diseases vitamin K rodenticide anti-coagulants racemic mixture liver accumulation accumulates clots 6.460441988950
10010421 Zaprinast 37762-06-4 ≥98% 2008-09-18 5.545101289134 zaprinast 2-(o-Propoxyphenyl)-8-azapurin-6-one; M&B 22,948 sildenafil viagra phophodiesterase cGMP PDE5 GRP35 inhibitors inhibits inhibition M&B 22948 55122-20-8 5.545101289134
10010947 β-cyano-L-Alanine 6232-19-5 ≥98% 2008-11-11 19.837716390423 -cyano-l-alanine BCA H2S gasotransmitter inhibitors inhibits inhibition CSE vasodilation inflammation sulfides 19.837716390423
Other Resources
Management Team Company Profile Company History ChemAssistant Tools FAQs Cayman Europe Cayman Pharma CaBRI Cayman Gear Press Releases Illustrations and Charts Key Research Area Posters Article Library Analysis Tools Conference Schedule Order Terms Browser Recommendation Privacy Statement Site Map

Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA

Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640

Copyright 2012 Cayman Chemical Company

Lost password?